Medtronic plc Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions
Medtronic plc (MDT) reported Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions of $140.00 million for the 12-month period ending 2026-04-24, per its 10-K filed 2026-06-18.
Financial Statements › Notes
us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions · last filed 2026-06-18
- Medtronic plc asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2026-04-24 was $50.00M, a 70.76% decline year-over-year.
- Medtronic plc asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2026-01-23 was $0.00.
- Medtronic plc asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2025-10-24 was $0.00.
- Medtronic plc asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2025-07-25 was $90.00M.
- Medtronic plc asset at fair value, changes in fair value resulting from changes in assumptions for fiscal 2026 was $140.00M, a 18.13% decline from fiscal 2025.
- Medtronic plc asset at fair value, changes in fair value resulting from changes in assumptions for fiscal 2025 was $171.00M, a 22.27% decline from fiscal 2024.
- Medtronic plc asset at fair value, changes in fair value resulting from changes in assumptions for fiscal 2024 was $220.00M.
- Medtronic plc asset at fair value, changes in fair value resulting from changes in assumptions for fiscal 2023 was $0.00.
| Period end | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 3 month | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 6 month | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 9 month | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 12 month |
|---|---|---|---|---|
| 2026-04-24 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $50.00M derived: sum of 2 quarters · filed 2026-06-18 | $50.00M derived: sum of 3 quarters · filed 2026-06-18 | $140.00M 10-K · filed 2026-06-18 |
| 2026-01-23 | $0.00 10-Q · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $90.00M 10-Q · filed 2026-02-24 | $261.00M derived: sum of 4 quarters · filed 2026-06-18 |
| 2025-10-24 | $0.00 10-Q · filed 2025-11-25 | $90.00M 10-Q · filed 2025-11-25 | $261.00M derived: sum of 3 quarters · filed 2026-06-18 | $261.00M derived: sum of 4 quarters · filed 2026-06-18 |
| 2025-07-25 | $90.00M 10-Q · filed 2025-08-26 | $261.00M derived: sum of 2 quarters · filed 2026-06-18 | $261.00M derived: sum of 3 quarters · filed 2026-06-18 | $261.00M derived: sum of 4 quarters · filed 2026-06-18 |
| 2025-04-25 | $171.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $171.00M derived: sum of 2 quarters · filed 2026-06-18 | $171.00M derived: sum of 3 quarters · filed 2026-06-18 | $171.00M 10-K · filed 2026-06-18 |
| 2025-01-24 | $0.00 10-Q · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 10-Q · filed 2026-02-24 | |
| 2024-10-25 | $0.00 10-Q · filed 2025-11-25 | $0.00 10-Q · filed 2025-11-25 | ||
| 2024-07-26 | $0.00 10-Q · filed 2025-08-26 | |||
| 2024-04-26 | $220.00M 10-K · filed 2025-06-20 | |||
| 2023-04-28 | $0.00 10-K · filed 2024-06-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |